Literature DB >> 32715001

Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy.

Ashwin Singh Parihar1, Apurva Sood1, Ashwani Sood1, Ajay Gulati2, Bhagwant Rai Mittal1.   

Abstract

We present the case of a 60-year-old man with metastatic neuroendocrine tumor of the ileum following ileal resection, being evaluated for 177Lu-based peptide receptor radionuclide therapy. 68Ga-DOTANOC PET/CT showed focal increased tracer uptake in the scrotal region without any morphologic changes on the corresponding CT images. Similar increased tracer uptake was seen on post-therapy whole-body imaging following 177Lu-DOTATATE therapy. An USG guided FNA revealed no malignant cells on cytopathologic examination. This case illustrates that focal testicular tracer uptake, may not always be pathological and can represent a normal physiologic variant, similar to the diffuse testicular somatostatin receptor expression as previously reported in literature.
© 2020 mums.ac.ir All rights reserved.

Entities:  

Keywords:  177Lu-DOTATATE; 68Ga-DOTANOC- PET/CT; DOTATOC; Neuroendocrine tumor; Physiologic; Somatostatin receptor; Testicular uptake

Year:  2020        PMID: 32715001      PMCID: PMC7354247          DOI: 10.22038/AOJNMB.2020.44324.1297

Source DB:  PubMed          Journal:  Asia Ocean J Nucl Med Biol        ISSN: 2322-5718


  19 in total

1.  Gallium-68 DOTATOC PET/CT in vivo characterization of somatostatin receptor expression in the prostate.

Authors:  Mila V Todorović-Tirnanić; Milan M Gajić; Vladimir B Obradović; Richard P Baum
Journal:  Cancer Biother Radiopharm       Date:  2014-01-22       Impact factor: 3.099

2.  68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.

Authors:  Valentina Ambrosini; Davide Campana; Lisa Bodei; Cristina Nanni; Paolo Castellucci; Vincenzo Allegri; Gian Carlo Montini; Paola Tomassetti; Giovanni Paganelli; Stefano Fanti
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

3.  Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Authors:  M Hofmann; H Maecke; R Börner; E Weckesser; P Schöffski; L Oei; J Schumacher; M Henze; A Heppeler; J Meyer; H Knapp
Journal:  Eur J Nucl Med       Date:  2001-10-31

4.  Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.

Authors:  Punit Sharma; Varun Singh Dhull; Saurabh Arora; Poonam Gupta; Rajeev Kumar; Prashant Durgapal; Arun Malhotra; Sunil Chumber; Ariachery C Ammini; Rakesh Kumar; Chandrasekhar Bal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-25       Impact factor: 9.236

5.  68Ga-DOTANOC PET/CT in an Atypical Extraskeletal Paravertebral Hemangioma Mimicking as Neurogenic Tumor in a Known Case of Breast Cancer.

Authors:  Shelvin Kumar Vadi; Bhagwant Rai Mittal; Ashwin Singh Parihar; Rajender Kumar; Harmandeep Singh; Gurpreet Singh
Journal:  Clin Nucl Med       Date:  2019-05       Impact factor: 7.794

6.  Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants.

Authors:  Olga Kagna; Natalia Pirmisashvili; Sagi Tshori; Nanette Freedman; Ora Israel; Yodphat Krausz
Journal:  AJR Am J Roentgenol       Date:  2014-12       Impact factor: 3.959

7.  Ectopic Cushing Syndrome (ECS): 68Ga-DOTANOC PET/CT Localizes the Site of Ectopic Adrenocorticotropic Hormone Production.

Authors:  Ashwin Singh Parihar; Bhagwant Rai Mittal; Shelvin Kumar Vadi; Rajender Kumar Basher; Anil Bhansali
Journal:  Clin Nucl Med       Date:  2018-10       Impact factor: 7.794

8.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Authors:  Michael S Hofman; W F Eddie Lau; Rodney J Hicks
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

9.  68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors.

Authors:  C Pettinato; A Sarnelli; M Di Donna; S Civollani; C Nanni; G Montini; D Di Pierro; M Ferrari; M Marengo; C Bergamini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-14       Impact factor: 9.236

10.  Incidental Meningioma on 68Ga-DOTANOC Positron-Emission Tomography.

Authors:  Ashwin Singh Parihar; Rajender Kumar Basher; Nivedita Rana; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2018 Apr-Jun
View more
  1 in total

1.  Nephrotoxicity after radionuclide therapies.

Authors:  Ashwin Singh Parihar; Sejal Chopra; Vikas Prasad
Journal:  Transl Oncol       Date:  2021-11-27       Impact factor: 4.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.